Maryland State Retirement & Pension System raised its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 135.8% in the third quarter, HoldingsChannel reports. The institutional investor owned 22,886 shares of the medical device company’s stock after acquiring an additional 13,182 shares during the period. Maryland State Retirement & Pension System’s holdings in Cooper Companies were worth $1,294,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently bought and sold shares of the company. BlackRock Inc. purchased a new position in shares of Cooper Companies during the second quarter valued at about $1,077,762,000. Generation Investment Management LLP purchased a new position in Cooper Companies during the 2nd quarter valued at approximately $356,304,000. Jupiter Topco LLC purchased a new position in Cooper Companies during the 2nd quarter valued at approximately $305,074,000. Bank of America Corp DE bought a new stake in Cooper Companies in the 2nd quarter worth approximately $144,125,000. Finally, Manning & Napier Advisors LLC purchased a new position in shares of Cooper Companies in the second quarter valued at $107,939,000. 24.39% of the stock is currently owned by institutional investors.
More Cooper Companies News
Here’s some of the latest news about COO:
- Positive Sentiment: A recent article highlights Cooper’s relatively high cash yield, suggesting investors may be overlooking a potential source of value. The supplied information does not include the article’s supporting figures or analysis. Why Is Everyone Ignoring Cooper Companies Stock’s High Cash Yield?
- Negative Sentiment: Rosen Law Firm says it is investigating potential securities claims tied to allegations that Cooper may have provided materially misleading business information. The notices encourage affected investors to contact the firm; they do not establish wrongdoing or indicate that a claim has been proven. The investigation could nevertheless weigh on sentiment and raise concerns about potential legal costs or reputational impact. Rosen investigation notice Rosen investor notice
Cooper Companies Stock Performance
Shares of COO opened at $62.65 on Monday. The company’s fifty day simple moving average is $58.49 and its 200-day simple moving average is $68.15. The company has a market cap of $11.91 billion, a P/E ratio of 21.38, a P/E/G ratio of 2.46 and a beta of 0.83. The company has a current ratio of 1.22, a quick ratio of 0.73 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a twelve month low of $51.01 and a twelve month high of $89.83.
Cooper Companies (NASDAQ:COO – Get Free Report) last released its quarterly earnings results on Wednesday, September 9th. The medical device company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.12 by $0.03. Cooper Companies had a net margin of 13.46% and a return on equity of 10.90%. The firm had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.10 billion. During the same period in the previous year, the company earned $0.49 EPS. The firm’s revenue for the quarter was up .5% compared to the same quarter last year. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. As a group, analysts expect that The Cooper Companies, Inc. will post 4.53 EPS for the current year.
Cooper Companies announced that its board has authorized a stock repurchase program on Wednesday, September 9th that allows the company to repurchase $3 billion in shares. This buyback authorization allows the medical device company to reacquire up to 22.7% of its shares through open market purchases. Stock buyback programs are often a sign that the company’s board believes its shares are undervalued.
Analysts Set New Price Targets
COO has been the topic of several research reports. Bank of America cut shares of Cooper Companies from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $80.00 to $65.00 in a research report on Thursday, September 10th. Stifel Nicolaus set a $70.00 price target on shares of Cooper Companies and gave the company a “buy” rating in a research note on Thursday, September 10th. UBS Group lowered their price objective on shares of Cooper Companies from $75.00 to $66.00 and set a “neutral” rating for the company in a research report on Thursday, September 10th. William Blair cut shares of Cooper Companies from an “outperform” rating to a “market perform” rating in a research note on Thursday, September 10th. Finally, Weiss Ratings downgraded shares of Cooper Companies from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, October 28th. Four analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, Cooper Companies has a consensus rating of “Hold” and an average price target of $68.60.
View Our Latest Research Report on COO
Insider Buying and Selling at Cooper Companies
In other Cooper Companies news, Director Paul A. Keel purchased 4,701 shares of Cooper Companies stock in a transaction dated Friday, September 11th. The shares were purchased at an average cost of $53.18 per share, for a total transaction of $249,999.18. Following the completion of the acquisition, the director owned 4,701 shares in the company, valued at $249,999.18. This represents a ∞ increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Lawrence Kurzius acquired 10,000 shares of the company’s stock in a transaction that occurred on Monday, September 14th. The shares were acquired at an average price of $53.91 per share, with a total value of $539,100.00. Following the acquisition, the director owned 21,099 shares in the company, valued at $1,137,447.09. This trade represents a 90.10% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders acquired 34,701 shares of company stock worth $1,880,039 over the last 90 days. Company insiders own 2.08% of the company’s stock.
About Cooper Companies
CooperCompanies is a global medical device company focused on vision care and women’s health. It serves customers in markets around the world through two primary businesses: CooperVision and CooperSurgical. CooperVision develops and sells contact lenses, including products for daily wear, astigmatism, presbyopia and myopia management. Its offerings include lenses made from silicone hydrogel and other materials, as well as specialty lens options. CooperSurgical provides products and services for women’s health and fertility care.
Further Reading
- Five stocks we like better than Cooper Companies
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.
